Inflammasome Therapeutics is focused on developing therapies for degenerative diseases such as Alzheimer’s disease, multiple sclerosis, macular degeneration, and type 2 diabetes.

By focusing on Inflammasome activation, we are working to treat these diseases through a new, innovative approach.

Explore Our Approach